- About Us
- Nano-Social Network
- Nano Consulting
- My Account
Ultratech, Inc. (UTEK 17.99, +1.22, +7.28%) today announced unaudited results for the three-month and six-month periods ended July 3, 2010.
For the second quarter of fiscal 2010, Ultratech reported net sales of $31.6 million as compared to $18.6 million during the second quarter of fiscal 2009. Ultratech's net income for the second quarter of 2010 was $3.6 million or $0.15 per share (diluted), as compared to a net loss of $0.5 million, or a net loss of $0.02 per share for the same quarter last year.
For the first six months of 2010, Ultratech reported net sales of $59.1 million compared to net sales of $44.3 million in the first six months of 2009. Ultratech reported net income of $5.6 million or $0.23 per share (diluted) during the first half of 2010, compared to a net loss of $0.3 million or a net loss of $0.01 per share for the first half of 2009.
Arthur W. Zafiropoulo, Chairman and Chief Executive Officer, stated, "We are truly pleased with the solid operating results accomplished during the second quarter. These results not only demonstrate the operating leverage and improved profitability achieved in concert with our growth in revenues, but reflect the current demand for Ultratech's products in the advanced packaging, laser processing and high-brightness LED (HBLED) markets coming from both integrated device manufacturers (IDMs) and foundries."
"Ultratech's business continues to benefit from our customers' ongoing push to shrink geometries, ramp production and move to advanced process nodes for smart mobile applications. As our customers move to leading-edge technology for cost-effective manufacturing solutions, Ultratech's product offerings are well positioned to provide enabling capabilities at a low overall cost- of-ownership, a key requirement for today's global electronics industry," concluded Zafiropoulo.
At July 3, 2010, Ultratech had $173 million in cash, cash equivalents and short-term investments. Working capital was $200 million and stockholders' equity was $8.73 per share based on 24,043,431 total shares outstanding on July 3, 2010.
Conference Call Information
The conference call will be broadcast live over the Internet beginning at 11:00 a.m. Eastern Time / 8:00 a.m. Pacific Time on Thursday, July 22, 2010. To listen to the call over the Internet or to obtain telephone dial-in information for the call, please go to Ultratech's web site at www.ultratech.com.
If you are unable to attend the live conference call, a replay will be available on Ultratech's web site. If you do not have Internet access, a replay of the call will be available three hours after the conclusion of the call and run until 9:00 p.m. Pacific Time, July 29, 2010. You may access the telephone replay by dialing 800-642-1687 for domestic callers, (706) 645-9291 for international callers and entering access code: 84045464.
Ultratech, Inc. /quotes/comstock/15*!utek (UTEK 18.02, +1.25, +7.45%) designs, manufactures and markets photolithography and laser processing equipment. Founded in 1979, the company's market-leading advanced lithography products deliver high throughput and production yields at a low, overall cost of ownership for bump packaging of integrated circuits and high-brightness LEDs. A pioneer of laser processing, Ultratech developed laser spike anneal technology, which increases device yield, improves transistor performance and enables the progression of Moore's Law for 45-nm and below production of state-of-the-art consumer electronics. Visit Ultratech online at: www.ultratech.com.
Certain of the statements contained herein, which are not historical facts and which can generally be identified by words such as "anticipates," "expects," "intends," "will," "could," "believes," "estimates," "continue," and similar expressions, are forward-looking statements under Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve risks and uncertainties, such as risks related to timing, delays, deferrals and cancellations of orders by customers, including as a result of semiconductor manufacturing capacity as well as our customers' financial condition and demand for semiconductors; cyclicality in the semiconductor and nanotechnology industries; general economic and financial market conditions including impact on capital spending, as well as difficulty in predicting changes in such conditions; rapid technological change and the importance of timely product introductions; customer concentration; our dependence on new product introductions and market acceptance of new products and enhanced versions of our existing products; lengthy sales cycles, including the timing of system installations and acceptances; lengthy and costly development cycles for laser-processing and lithography technologies and applications; integration, development and associated expenses of the laser processing operation; pricing pressures and product discounts; high degree of industry competition; intellectual property matters; changes in pricing by us, our competitors or suppliers; international sales; timing of new product announcements and releases by us or our competitors; ability to volume produce systems and meet customer requirements; sole or limited sources of supply; effect of capital market fluctuations on our investment portfolio; ability and resulting costs to attract or retain sufficient personnel to achieve our targets for a particular period; dilutive effect of employee stock option grants on net income per share, which is largely dependent upon our achieving and maintaining profitability and the market price of our stock; mix of products sold; outcome of litigation; manufacturing variances and production levels; timing and degree of success of technologies licensed to outside parties; product concentration and lack of product revenue diversification; inventory obsolescence; asset impairment; changes to financial accounting standards; effects of certain anti-takeover provisions; future acquisitions; volatility of stock price; foreign government regulations and restrictions; business interruptions due to natural disasters or utility failures; environmental regulations; and any adverse effects of terrorist attacks in the United States or elsewhere, or government responses thereto, or military actions in Iraq, Afghanistan and elsewhere, on the economy, in general, or on our business in particular. Such risks and uncertainties are described in Ultratech's SEC reports including its Annual Report on Form 10-K filed for the year ended December 31, 2009 and Quarterly Report on Form 10Q for the quarter ended April 3, 2010. Due to these and additional factors, the statements, historical results and percentage relationships set forth herein are not necessarily indicative of the results of operations for any future period. These forward-looking statements are based on management's current beliefs and expectations, some or all of which may prove to be inaccurate, and which may change. We undertake no obligation to revise or update any forward-looking statements to affect any event or circumstance that may arise after the date of this release.
View the CONDENSED CONSOLIDATED BALANCE SHEETS here www.marketwatch.com/story/ultratech-announces-second-quarter-2010-results-2010-07-22?reflink=MW_news_stmp
For more information, please click here
Bruce Wright, 408-321-8835
Sr. Vice President, Finance/CFO
Laura Rebouche', 408-321-8835
Vice President of Investor Relations, Corporate and
Copyright © MarketwatchIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016
Nanometrics Reports Second Quarter 2016 Financial Results July 26th, 2016